Results 141 to 150 of about 245,168 (213)
Lung- and diaphragm-protective mechanical ventilation in acute respiratory distress syndrome. [PDF]
Plens GM +14 more
europepmc +1 more source
Abstract Purpose To evaluate the evidence of internal structure validity of the nursing outcome (NO) “Mechanical Ventilation Weaning Response: Adult (0412)” of the NOs classification for critically ill COVID‐19 patients. Methods A methodological study focused on internal structural validation, part of a multicenter study, was carried out in the ...
Aline Batista Maurício +8 more
wiley +1 more source
Optimizing endpoints in early phase clinical trials of acute respiratory distress syndrome. [PDF]
Boyle AJ +4 more
europepmc +1 more source
Timing of Delivery in Preeclampsia: Time to Reconsider?
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Rebecca Horgan +5 more
wiley +1 more source
Beyond abstinence: Redefining success in cannabis use disorder treatment
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin +3 more
wiley +1 more source
One syndrome, many diseases: toward precision pharmacotherapy in acute respiratory distress syndrome. [PDF]
Merola R, Battaglini D, Rocco PRM.
europepmc +1 more source
Population: Adults with non‐odontogenic orofacial pain, including temporomandibular disorders (TMDs), burning mouth syndrome (BMS), post‐traumatic trigeminal neuropathy (PTTN), and other chronic non‐odontogenic orofacial pain referral cohorts. Exposure: Sleep disturbances assessed using the Pittsburgh Sleep Quality Index (PSQI), Basic Nordic Sleep ...
Jainy Shah +3 more
wiley +1 more source
The diagnosis and prognosis role of miR-155 in neonatal acute respiratory distress syndrome. [PDF]
Zhou Y +6 more
europepmc +1 more source
We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija +6 more
wiley +1 more source

